Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Market Cap	811.78M
Revenue (ttm)	2.36B
Net Income (ttm)	101.32M
Shares Out	863.60M
EPS (ttm)	0.12
PE Ratio	8.03
Forward PE	n/a
Dividend	0.05 (5.38%)
Ex-Dividend Date	May 23, 2025

Volume	274,000
Average Volume	287,050
Open	0.9100
Previous Close	0.9300
Day's Range	0.9100 - 0.9400
52-Week Range	0.8200 - 1.2800
Beta	0.63
RSI	59.95
Earnings Date	May 23, 2025

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. In addition, the company manufactures and sells food and Chinese herbs. Further, it offers detection and testing services; and manages properties. ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,577
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3737

Financial Performance

In 2024, HKG:3737's revenue was 2.21 billion, an increase of 8.05% compared to the previous year's 2.05 billion. Earnings were 95.21 million, a decrease of -41.51%.

Financial numbers in CNY